Replay available

TRxADE HEALTH, Inc. (MEDS) Q4 2022 Earnings Call

TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q4 2022 earnings conference call, held 2023-03-27. Replay captured from the company's public earnings webcast.

Mon, March 27, 2023 at 5:30 PMendedReplay
TRxADE HEALTH, Inc. (MEDS) Q4 2022 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Howard Halpern

Analyst, Taglage Brothers

Alan Klee

Analyst, Maxim Group

Prashant Patel

Chief Financial Officer

Surin Ajarapu

Founder, Chairman and Chief Executive Officer

Replay transcript excerpt

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to TRAXAID Health's 2022 Annual Earnings Conference Call. During today's presentation, all parties will be in a listen-only mode. Following the presentation, the conference will be open for questions. The earnings press release accompanying this conference call was issued at the close of the market today. The company's annual report, which includes additional information regarding the company's results of operations for the year ended December 31st, 2022, was filed with the SEC earlier today. On our call today is TraxSafe Health's founder, chairman and chief executive officer, Surin Ajarapu, and Prashant Patel, its chief financial officer. The replay of this call and webcast will be available for the next 30 days on the company's website under the NASDAQ Meds link. The company's website also includes more supporting industry information. At this time, I'd like to turn the call over to Prashant Patel, the company's chief financial officer. Prashant, the floor is yours. Thank you, operator, and thank you for joining us today. I'd like to welcome you to our 2022 annual financial results conference call. Our press release announcing our 2022 financial results was issued after the close of market today and is posted on our website. We have also put a press release to the SEC on Form 8K. Statements made on this call and webcast will include forward-looking statements. These statements include but are not limited to our outlook for the company and statements that estimate of future projects, results of operation, or the performance of the company, including the potential continued impact of COVID-19, increased interest rates and inflation on the company's business, and results of operation. These state...

More from Scienture Holdings, Inc.